Advancing Pharmaceutical Innovation from Research to Scalable Manufacturing
Zeeviezee Bio Pharma is an R&D-driven pharmaceutical development center with global capabilities in formulation research, analytical development, API research and pilot-scale manufacturing. Our integrated scientific and manufacturing capabilities enable us to support pharmaceutical development from early-stage research and formulation optimization through analytical characterization, scale-up and pilot manufacturing.
With expertise spanning oral solid formulations, topical formulations, nasal sprays, solutions and APIs, Zeeviezee Bio Pharma provides a platform for developing innovative, scalable and commercially relevant pharmaceutical products.
Our approach brings together scientific expertise, formulation technologies, analytical capabilities and manufacturing infrastructure to help transform pharmaceutical concepts into development-ready products.
Pilot Manufacturing Capabilities
Zeeviezee Bio Pharma has pilot manufacturing approvals for multiple pharmaceutical dosage forms, enabling the transition of products from laboratory-scale development toward scalable manufacturing.
Our pilot manufacturing capabilities include:
Oral Solid Formulations
Development and pilot-scale manufacturing support for oral solid dosage forms, including formulation and process optimization.
Topical Formulations
Pilot manufacturing capabilities for topical pharmaceutical products, supporting formulation development, process optimization and scale-up.
Nasal Sprays
Development and pilot-scale manufacturing support for nasal spray formulations, including formulation and process development.
Solutions
Pilot manufacturing capabilities for pharmaceutical solution-based products, supporting development through scalable processing.
These capabilities help bridge the gap between laboratory research and commercial manufacturing, allowing pharmaceutical products to be evaluated under conditions relevant to larger-scale production.
API Research & Manufacturing
In addition to formulation development, Zeeviezee Bio Pharma has API manufacturing facilities supported by R&D capabilities for the development of new APIs and intermediates.
Our API development platform focuses on:
- New API research and development
- Intermediate development
- Process development
- Process optimization
- Route evaluation
- Analytical characterization
- Impurity profiling
- Process scalability
- Laboratory-to-pilot scale-up
- Kilogram-scale development and manufacturing
Our capabilities extend to scalable development at kilogram levels, providing an important bridge between laboratory research and larger-scale manufacturing requirements.
Integrated API-to-Formulation Development
One of the key strengths of Zeeviezee Bio Pharma is the ability to integrate API research, analytical development and formulation R&D within a connected development environment.
This integrated model enables our teams to work across different stages of pharmaceutical development:
API Research → Process Development → Analytical Development → Formulation Development → Scale-Up → Pilot Manufacturing
By bringing these capabilities together, we aim to improve development efficiency, facilitate technical decision-making and support the progression of pharmaceutical products toward commercial readiness.
Regulatory & Manufacturing Approvals
Zeeviezee Bio Pharma has obtained CT-11, CT-12 and Form 20 approvals from the Drug Control Administration (DCA) for various formulations and APIs.
These regulatory approvals support our capabilities in pharmaceutical development and pilot manufacturing and demonstrate our commitment to operating within applicable regulatory and quality requirements.
Our approved capabilities include areas covering:
- Pharmaceutical formulations
- API-related activities
- Pilot manufacturing
- Development-scale manufacturing activities
Specific approval scope should be presented on the website exactly as stated in the applicable DCA approval documents.
From Discovery to Development
At Zeeviezee Bio Pharma, our objective is to create an environment where pharmaceutical ideas can progress through multiple stages of development under one integrated platform.
Our development pathway encompasses:
01 — Research
Identification and evaluation of APIs, intermediates, formulations and drug-delivery opportunities.
02 — Development
Formulation optimization, process development and analytical method development.
03 — Characterization
Comprehensive analytical evaluation, stability assessment, dissolution testing and degradation studies.
04 — Scale-Up
Translation of laboratory processes into scalable manufacturing processes.
05 — Pilot Manufacturing
Manufacturing of development and pilot batches across approved dosage-form categories.
06 — Technology Transfer
Supporting the transfer of optimized processes and analytical methods toward larger-scale manufacturing environments.
Our Scientific Focus
Zeeviezee Bio Pharma focuses on developing pharmaceutical technologies that address the practical challenges of modern drug development.
Our scientific focus includes:
Formulation R&D
Developing optimized and scalable dosage forms.
Analytical R&D
Generating reliable analytical methods and scientific data to support product development.
API R&D
Developing new APIs and intermediates with scalable processes.
Drug Delivery Technologies
Exploring innovative approaches to improve drug delivery and product performance.
Process Development
Optimizing processes for reproducibility, efficiency and scale-up.
Pilot Manufacturing
Translating research outcomes into controlled development-scale manufacturing.
From Molecule to Medicine
Research. Develop. Scale. Manufacture.
At Zeeviezee Bio Pharma, we are building an integrated pharmaceutical R&D and manufacturing platform designed to transform scientific concepts into scalable, development-ready pharmaceutical products.
Zeeviezee Bio Pharma — Advancing Pharmaceutical Research Through Integrated R&D and Manufacturing.